18 subscribers
ออฟไลน์ด้วยแอป Player FM !
May 2020: Psychedelics and Psychedelic-Assisted Psychotherapy
Manage episode 260482505 series 2608040
Executive Editor Michael Roy speaks with Collin Reiff, M.D., and William McDonald, M.D., about their evidence-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.
- How hallucinogens were first used, and some of the key individuals involved in the development of these drugs for medical use [2:23]
- What led to the worry about use of these compounds in the 1960s, and what actions did U.S. policymakers take at the time? [5:35]
- How have opinions changed from the 1960s to the present? [7:01]
- How the authors conducted their research [8:23]
- How the authors determined which drugs to examine [9:38]
- What findings stood out to the authors? [10:28]
- Relationships between the psychological effects and the neurobiology of psychedelic compounds [12:59]
- How ketamine came to be used in clinical care, and what studies have shown about its safety and effectiveness [14:18]
- An outline of psycholytic therapy and psychedelic therapy [17:16]
- What is the potential for these kinds of drugs to be misused? [19:24]
- Conclusions that researchers, clinicians, and other mental health professionals should take away [21:15]
- Recommendations for further research in this area [22:20]
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org
Image: detail from a 1978 painting by Flournoy Holmes, "Fire Being" (acrylic, 36 in x 42 in). Image provided courtesy of the artist. For this and other works, visit flournoyholmes.com.
203 ตอน
Manage episode 260482505 series 2608040
Executive Editor Michael Roy speaks with Collin Reiff, M.D., and William McDonald, M.D., about their evidence-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.
- How hallucinogens were first used, and some of the key individuals involved in the development of these drugs for medical use [2:23]
- What led to the worry about use of these compounds in the 1960s, and what actions did U.S. policymakers take at the time? [5:35]
- How have opinions changed from the 1960s to the present? [7:01]
- How the authors conducted their research [8:23]
- How the authors determined which drugs to examine [9:38]
- What findings stood out to the authors? [10:28]
- Relationships between the psychological effects and the neurobiology of psychedelic compounds [12:59]
- How ketamine came to be used in clinical care, and what studies have shown about its safety and effectiveness [14:18]
- An outline of psycholytic therapy and psychedelic therapy [17:16]
- What is the potential for these kinds of drugs to be misused? [19:24]
- Conclusions that researchers, clinicians, and other mental health professionals should take away [21:15]
- Recommendations for further research in this area [22:20]
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org
Image: detail from a 1978 painting by Flournoy Holmes, "Fire Being" (acrylic, 36 in x 42 in). Image provided courtesy of the artist. For this and other works, visit flournoyholmes.com.
203 ตอน
ทุกตอน
×
1 February 2025: Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders 44:45

1 December 2024: Discrimination Exposure, Neural Reactivity to Stress, and Psychological Distress 29:50

1 November 2024: Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants 27:36

1 October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder 36:01

1 September 2024: Peer Social Genetic Effects and the Etiology of Substance Use Disorders, Major Depression, and Anxiety Disorder in a Swedish National Sample 30:18

1 August 2024: Sexual Identity Continuity and Change in a U.S. National Probability Sample of Sexual Minority Adults: Associations With Mental Health and Problematic Substance Use 29:32

1 July 2024: Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder 31:20

1 March 2024: Intergenerational Effects of the Fast Track Intervention on Next-Generation Child Outcomes: A Preregistered Randomized Clinical Trial 27:55

1 February 2024: Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019 21:56

1 January 2024: Predicting Acute Changes in Suicidal Ideation and Planning: A Longitudinal Study of Symptom Mediators and the Role of the Menstrual Cycle in Female Psychiatric Outpatients With… 35:26

1 December 2023: Racial and Ethnic Disparities in COVID-19-Related Stressor Exposure and Adverse Mental Health Outcomes Among Health Care Workers 28:01
ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ